John J Cush, MD
John J. Cush, MD,is director of clinical rheumatology at the Baylor Research Institute, and Professor of medicine and rheumatology at Baylor University Medical Center in Dallas, Texas. Dr Cush received his medical degree from St. George’s University School of Medicine in Grenada, West Indies. He completed his rheumatology training at The University of Texas Health Science Center and Parkland Memorial Hospital in Dallas.
Dr Cush’s research focuses on translational and drug development projects. His career interests and expertise includes rheumatoid arthritis, spondyloarthritis, Still’s disease, drug safety, biologic and novel therapies, pregnancy and nutraceuticals. His extensive research in the field of rheumatology is chronicled in over 140 journal articles and numerous textbook chapters. Dr Cush has co-authored the medical texts, Rheumatology: Diagnosis and Therapeutics (2nd edition, 2005), Rheumatoid Arthritis: Diagnosis and Treatment (4th edition, 2014) and the on-line textbook RheumaKnowledgy.com (2014).
He has served on the Arthritis Advisory Committee for the Food and Drug Administration, held numerous leadership positions for the American College of Rheumatology, editorial positions for the Journal of Rheumatology, seminars in Arthritis & Rheumatism and is past editor of the ACR's Hotline and Drug Safety Quarterly. He is the executive editor of RheumNow.com - a news, information and education network dedicated to rheumatologists. He is also co-author and editor of RheumaKnowledgy.com.
Consultancy – AbbVie, Amgen, BMS, Genentech, Horizon, Janssen, Lilly, Novartis, Pfizer, UCB; Clinical Investigator – AbbVie, Celgene, Janssen, Novartis, Pfizer, AstraZeneca